Longitudinal Imaging Biomarkers of Disease Progression in DLB
Status:
Enrolling by invitation
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The Researchers are trying to determine the paths of change in imaging biomarkers of Dementia
with Lewy bodies (DLB) and their associations with rate of cognitive and functional decline.